Alafair Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Alafair Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10450
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alafair Biosciences Inc (Alafair Biosciences) is a medical device company that develops and commercialize surgical products for soft tissue repair and protection applications. The company develops products based on a non-cell adhesive hydrogel technology to protect and manage advanced wound healing. It offers tendon protector, an ultrathin, sutureless, bioresorbable hydrogel that protects tendon gliding by separating injured tendon from surrounding tissues. Alafair Biosciences offers tendon protector, which is made of polysaccharides alginate and hyaluronic acid, and contains no animal derived components. The company’s product is used in procedures such as suture of tendon or tendon sheath, tenodesis, reattachment of tendon, tenolysis, repair of tendorn in hand, wrist and forearm, and other procedures of the hand or extremities. Alafair Biosciences is headquartered in Austin, Texas, the US.

Alafair Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alafair Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alafair Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Alafair Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alafair Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Alafair Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Alafair Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Alafair Biosciences Raises USD0.5 Million in Venture Financing 10
Alafair Biosciences Raises USD1 Million in Venture Financing 11
Alafair Biosciences Raises USD2 Million in Series A Financing 12
Alafair Biosciences Raises USD1 Million Financing 13
Alafair Biosciences Raises USD1 Million in Venture Financing 14
Alafair Biosciences Inc – Key Competitors 15
Alafair Biosciences Inc – Key Employees 16
Alafair Biosciences Inc – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Alafair Biosciences Inc, Medical Equipment, Key Facts 2
Alafair Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Alafair Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alafair Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Alafair Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alafair Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Alafair Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Alafair Biosciences Raises USD0.5 Million in Venture Financing 10
Alafair Biosciences Raises USD1 Million in Venture Financing 11
Alafair Biosciences Raises USD2 Million in Series A Financing 12
Alafair Biosciences Raises USD1 Million Financing 13
Alafair Biosciences Raises USD1 Million in Venture Financing 14
Alafair Biosciences Inc, Key Competitors 15
Alafair Biosciences Inc, Key Employees 16

List of Figures
Alafair Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Alafair Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Alafair Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Alafair Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Alafair Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Alafair Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Alafair Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Alafair Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Alafair Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Europlasma SA (ALEUP):電力:M&Aディール及び事業提携情報
    Summary Europlasma SA (Europlasma) is a leading provider of clean technology and renewable energy solutions in Europe. The company along with its group companies offers plasma solutions to treat gas and hazardous waste and conducts waste disposal and power production from waste and biomass and recyc …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Sodexo SA:企業のM&A・事業提携・投資動向
    Sodexo SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sodexo SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Advanced Enzyme Technologies Ltd:企業の戦略・SWOT・財務情報
    Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report Summary Advanced Enzyme Technologies Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Meidensha Corporation:企業の戦略・SWOT・財務情報
    Meidensha Corporation - Strategy, SWOT and Corporate Finance Report Summary Meidensha Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Willis Lease Finance Corp (WLFC):企業の財務・戦略的SWOT分析
    Willis Lease Finance Corp (WLFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Biocept Inc (BIOC):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell l …
  • Bioceptive Inc:医療機器:M&Aディール及び事業提携情報
    Summary Bioceptive Inc (Bioceptive) is a medical device company that provides medical devices for a variety of gynaecological procedures. The company offers products such as intrauterine devices, intuitive IUD insertion systems and IUD inserters, among others. Its intrauterine devices offer less tra …
  • Yamana Gold Inc.:企業の戦略・SWOT・財務分析
    Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report Summary Yamana Gold Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • American Airlines Group Inc (AAL):企業の財務・戦略的SWOT分析
    American Airlines Group Inc (AAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Sunesis Pharmaceuticals Inc (SNSS):製薬・医療:M&Aディール及び事業提携情報
    Summary Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's Vosaroxin is being developed in Phase III clinical trials for the treatment of acute myeloid leukemia (AML). …
  • Celsion Corp (CLSN)-医療機器分野:企業M&A・提携分析
    Summary Celsion Corp (Celsion) is an oncology company that focuses on developing a portfolio of new cancer treatments, including directed chemotherapies, RNA based therapies and DNA-mediated immunotherapy. The company’s three platform technologies including Lysolipid Thermally Sensitive Liposomes (L …
  • Liberty Holdings Ltd:戦略・SWOT・企業財務分析
    Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Liberty Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Seres Therapeutics Inc (MCRB):企業の財務・戦略的SWOT分析
    Summary Seres Therapeutics Inc (Seres), is a microbiome therapeutics platform company that develops a novel class of biological drugs. The company creates a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis. The company’ …
  • Beazer Homes USA, Inc.:企業の戦略・SWOT・財務分析
    Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beazer Homes USA, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Zavante Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Zavante Therapeutics Inc (Zavante), formerly SG Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops novel therapies for the treatment of infectious diseases such as due to multi-drug resistant (MDR) bacteria. The company offers drugs for the treatment of diseases …
  • Takara Bio Inc (4974):製薬・医療:M&Aディール及び事業提携情報
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • Netflix, Inc.:企業の戦略・SWOT・財務情報
    Netflix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Korea Midland Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea Midland Power Co., Ltd. (Komipo), a subsidiary of Korea Electric Power Corporation, is an electric utility which generates electricity; operates power plants; and provides various energy services. The company produces electricity from bituminous coal, anthracite coal, liquefied natural …
  • QuadGraphics Inc (QUAD):企業の財務・戦略的SWOT分析
    QuadGraphics Inc (QUAD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆